Rachelle Amanda Rodriguez, ARNP

Rachelle Rodriguez practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Rachelle Rodriguez's NPI, 1528503661, was assigned on December 28, 2016. Rachelle Rodriguez holds Florida license ARNP9272647.

Rachelle Rodriguez's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Rachelle Rodriguez's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Rachelle Rodriguez is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Rachelle Rodriguez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachelle Rodriguez practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Rachelle Rodriguez's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Rachelle Rodriguez is licensed in Florida.

CMS data shows 40 Medicare services from Rachelle Rodriguez across 2 procedure codes in 2024, all of them office visits, for 79 Medicare patients. Medicare paid $4,124 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Rachelle Rodriguez in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachelle Rodriguez's median patient age at 72, with 21% women.

In 2024, Rachelle Rodriguez wrote 138 Medicare Part D claims for 85 patients. 97% of them were for generic drugs. CMS names the drug for 98 of them, across 4 drugs with 11 or more claims each, at $1,355 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Rachelle Rodriguez for performance year 2024, reported as part of a group. Rachelle Rodriguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Rachelle Rodriguez from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 63% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,343.